Fundz
Following Cidara Therapeutics?

Get the free weekly executive digest

The latest leadership moves, like Cidara Therapeutics’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Cidara Therapeutics Appoints Jim Beitel As Chief Business Officer

RECENTLY ACQUIREDAug 19, 2024almost 2 years ago

Position

Chief Business Officer

Company

Cidara Therapeutics

Jim Beitel
San DiegoBiotechnology

Description

Cidara Therapeutics, Inc. announces the appointment of Jim Beitel, MBA, as its Chief Business Officer, adding a biotech veteran with over two decades of business development, strategy, and operational experience to the management team. The appointment comes at a pivotal time for the company given the expansive partnering opportunities created by its Cloudbreak pipeline, especially with CD388, the universal influenza preventative, entering a Phase 2b trial in the fall.

Company Information

Company

Cidara Therapeutics

Location

San Diego, California, United States

About

Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel DFCs comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment. Cidara’s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Cidara Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.